Institutional investors purchased a net $461.7 thousand shares of INSM during the quarter ended December 2013 and now own 71.37% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLS CAPITAL MANAGEMENT, INC. Bought 1.9 Million shares of Insmed Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 700.4 Thousand shares of Insmed Inc
FRANKLIN ADVISERS, INC. Bought 450.1 Thousand shares of Insmed Inc